| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 105 |
| 1 | MYCOPHENOLATE MOFETIL | 100 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 100 |
| 3 | TACROLIMUS | 99 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 87 |
| 5 | TACROLIMUS OINTMENT 0.1% | 87 |
| 6 | PREDNISOLONE | 78 |
| 7 | PREDNISOLONE ORAL | 78 |
| 8 | PREDNISOLONE ORAL SOLUTION | 78 |
| 9 | RITUXIMAB | 75 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TECOVIRIMAT MONOHYDRATE | 1 | 0.0096 |
| 1 | HISTAMINE | 1 | 0.0069 |
| 2 | NELFINAVIR MESYLATE | 11 | 0.0053 |
| 3 | MARAVIROC | 11 | 0.0048 |
| 4 | DEXCHLORPHENIRAMINE MALEATE | 4 | 0.0040 |
| 5 | BIRCH TRITERPENES | 1 | 0.0036 |
| 6 | PRAZIQUANTEL | 1 | 0.0033 |
| 7 | ALCLOMETASONE DIPROPIONATE | 1 | 0.0032 |
| 8 | COLISTIMETHATE SODIUM | 5 | 0.0031 |
| 9 | ADALIMUMAB-AACF | 1 | 0.0030 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] | 1 | 0.0096 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 11 | 0.0048 |
| 2 | Anthelmintic [EPC] | 5 | 0.0017 |
| 3 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 3 | 0.0017 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 21 | 0.0016 |
| 5 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 10 | 0.0011 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 23 | 0.0011 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 24 | 0.0011 |
| 9 | Prostacycline [EPC] | 1 | 0.0011 |